Six-Year Rate of Visual Field Progression in the Laser in Glaucoma and Ocular Hypertension Trial.
Giovanni Montesano, David P Crabb, David F Garway-Heath, David M Wright, Evgenia Konstantakopoulou, Neil Nathwani, Giovanni Ometto, Gus Gazzard
Summary
First-line SLT was more effective than drops at preserving VF.
Abstract
PURPOSE
To compare the 6-year rate of visual field (VF) progression in the 2 arms of the Laser in Ocular Hypertension and Glaucoma Trial (LiGHT), comparing selective laser trabeculoplasty (SLT) and drops as first treatment in ocular hypertension (OHT) and open-angle glaucoma (OAG).
DESIGN
Post hoc analysis of data from randomized clinical trial.
PARTICIPANTS
Patients with newly diagnosed OHT/OAG recruited in the LiGHT trial.
METHODS
In each patient, we selected the better (baseline mean deviation [MD]) eligible eye with at least 3 reliable VFs (false-positive errors < 15%) over at least 6 months. We estimated the rate of MD progression using a published hierarchical linear mixed effect model (LMM), designed to increase precision by minimizing the effect of perimetric learning and test-retest noise. Secondary analyses were performed to assess the differences in rate across baseline severity groups (OHT, mild OAG, and moderate/severe OAG); the effect of glaucoma surgery and switch to SLT in the drops-first arm, by truncating the VF series; and the effect of cataract and cataract surgery, by using the mean pattern deviation (MPD) instead of the MD.
MAIN OUTCOME MEASURE
Mean difference in the rate of VF MD progression between patients in the SLT-first arm and drops-first arm.
RESULTS
Data from 710 eyes (482 with OAG and 354 in the SLT-first arm) were analyzed. The 2 arms had similar baseline MD (P = 0.7). The average intraocular pressure (IOP) during follow-up was 16.1 [14.2-18.2] for the drops-first arm and 16.8 [14.6-18.6] in the SLT-first arm (median [interquartile range], P = 0.057). The mean [95% credible interval] MD rate was -0.37 [-0.43 to -0.31] decibels (dB)/year in the drops-first arm and -0.26 [-0.31 to -0.21] dB/year in the SLT-first arm (P = 0.007). When stratified by severity, this difference was significant only in mild OAG (P = 0.035, the largest sub-group). The secondary analyses largely confirmed the main results. The difference in MPD rate was also significantly slower in the SLT-first arm (P < 0.001).
CONCLUSIONS
First-line SLT was more effective than drops at preserving VF. Selective laser trabeculoplasty should be preferred as the first line of treatment in newly diagnosed OHT and OAG eyes. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.
Keywords
More by Giovanni Montesano
View full profile →Visual Field Outcomes from the Multicenter, Randomized Controlled Laser in Glaucoma and Ocular Hypertension Trial (LiGHT).
Efficacy of Repeat Selective Laser Trabeculoplasty in Medication-Naive Open-Angle Glaucoma and Ocular Hypertension during the LiGHT Trial.
A Comparison between the Compass Fundus Perimeter and the Humphrey Field Analyzer.
Top Research in IOP & Medical Therapy
Browse all →The Complications of Myopia: A Review and Meta-Analysis.
Inflammation in Glaucoma: From the back to the front of the eye, and beyond.
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up.
In the Knowledge Library
Discussion
Comments and discussion will appear here in a future update.